We do a few things, but those few things must be the best in the world: Novo Nordisk’s top exec

Maziar Mike Doustdar, executive VP, Novo Nordisk; image credit: Company

Synopsis
Novo Nordisk, the most valuable pharmaceutical company in the world, turned 100 last year. While it is largely known for its insulins, its anti-obesity drugs are making waves of late. Maziar Mike Doustdar, executive vice-president, international operations at Novo Nordisk tells ET Prime the beliefs that distinguish the company.

Danish pharmaceutical company Novo Nordisk celebrated its centenary last year. Yet, it has mostly kept a low profile. Known for a spectrum of insulins, the company has retained a strong grip on its market share. But a big surprise was in store beyond insulins. After two decades of research by its scientists, Novo Nordisk landed a remarkable feat. First Ozempic and then Wegovy, the two drugs were found very effective in cutting obesity. The